Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Magainin Pharm (MAGN) -- Ignore unavailable to you. Want to Upgrade?

To: Shlepper who wrote (164)	1/26/1999 11:03:00 AM
From: kech	Read Replies (1) \| Respond to of 233

Shep- Magn to be reviewed by FDA by March 4.

To: Shlepper who wrote (164)	2/11/1999 11:27:00 AM
From: Link Lady	Read Replies (1) \| Respond to of 233

Could you tell me what companies are involved here(with making and marketing). Just came across this news release. newswire.ca Video B-roll via satellite - a new drug that helps to speed the healing of diabetic foot ulcers TORONTO, Feb. 11 /CNW/ - The following Video News Release footage is available at the listed times and co-ordinates. DATE OF FEED: Thursday, February 11, 1999 TIME OF FEED: 13:00 to 13:30 (ET) CO-ORDINATES: ANIK E2, C-Band, Transponder 3B, Audio 6.2 & 6.8 PEGAD Available at: DOME TRANSMIT 1, DPA 18 STORY SUMMARY: A new biotechnology wound healing therapeutic that both enhances and speeds healing has recently been approved by Health Canada's Therapeutic Products Program. REGRANEX, marketed by Janssen-Ortho Inc., is the first of a new class of wound healing drugs, growth factors, that work by actively stimulating the body's natural healing process so that the wound fills with new, healthy tissue. This is a breakthrough for people with diabetic foot ulcers - ulcers that often just don't heal, risking infection, gangrene, amputation and even death. STATIONS, FOR FURTHER INFORMATION, PLEASE CALL: Krista Webster, Deborah Etsten, Julie Hoernig, or Leslie Wood at Lexicomm Communications, (416) 368-0208. For technical information prior to the feed please call Joel Rosenblum, CNW Broadcast, (416) 863-2096. During the feed call Dome Productions at (416) 341-2001. As with all CNW Broadcast feeds, this release is offered for your free and unrestricted news use. Comments regarding content and quality are welcome.